1. Home
  2. KNSL vs ICLR Comparison

KNSL vs ICLR Comparison

Compare KNSL & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kinsale Capital Group Inc.

KNSL

Kinsale Capital Group Inc.

HOLD

Current Price

$327.51

Market Cap

8.3B

Sector

Finance

ML Signal

HOLD

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$102.04

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KNSL
ICLR
Founded
2009
1990
Country
United States
Ireland
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
8.2B
IPO Year
2016
2001

Fundamental Metrics

Financial Performance
Metric
KNSL
ICLR
Price
$327.51
$102.04
Analyst Decision
Hold
Buy
Analyst Count
11
13
Target Price
$403.45
$178.62
AVG Volume (30 Days)
237.3K
992.7K
Earning Date
04-23-2026
04-30-2026
Dividend Yield
0.31%
N/A
EPS Growth
21.77
N/A
EPS
4.88
N/A
Revenue
$1,873,987,000.00
N/A
Revenue This Year
$5.60
N/A
Revenue Next Year
$7.88
N/A
P/E Ratio
$70.35
$12.91
Revenue Growth
18.04
N/A
52 Week Low
$321.97
$66.57
52 Week High
$512.76
$211.00

Technical Indicators

Market Signals
Indicator
KNSL
ICLR
Relative Strength Index (RSI) 34.58 39.35
Support Level $321.97 $95.75
Resistance Level $364.61 $114.75
Average True Range (ATR) 11.64 4.87
MACD -1.18 -0.82
Stochastic Oscillator 13.65 13.20

Price Performance

Historical Comparison
KNSL
ICLR

About KNSL Kinsale Capital Group Inc.

Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Share on Social Networks: